Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1

Interventions

Dexamethasone 129 Lenalidomide 70 Cyclophosphamide 70 Bortezomib 69 Calcium Dobesilate 50 fludarabine 44 pomalidomide 40 daratumumab 37 carfilzomib 33 fludarabine phosphate 31 Melphalan 25 dexamethasone acetate 20 dexamethasone 21-phosphate 20 auricularum 18 Filgrastim 18 Whole-Body Irradiation 14 Biopsy 13 isatuximab 12 Vorinostat 12 Tacrolimus 12 Peripheral Blood Stem Cell Transplantation 12 Magnetic Resonance Spectroscopy 12 Granulocyte Colony-Stimulating Factor 12 Specimen Handling 11 Sirolimus 11 ixazomib 10 belantamab mafodotin 10 Panobinostat 10 Mycophenolic Acid 10 Cyclosporine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Multiple Myeloma × ferric pyrophosphate × Clear all

NCT03506802 2020-07-24

NYSCT MM

Jonsson Comprehensive Cancer Center

Phase 1 Withdrawn

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡